JYNNEOS

GPTKB entity

Statements (28)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:age 18 years and older
gptkbp:alsoKnownAs Imvamune
Imvanex
gptkbp:approvalYear 2019
gptkbp:approvedBy gptkb:FDA
prevention of monkeypox
prevention of smallpox
gptkbp:contains Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN)
gptkbp:contraindication severe allergic reaction to vaccine components
gptkbp:countryOfOperation gptkb:Canada
gptkb:European_Union
gptkb:United_States
gptkbp:dosingSchedule two doses, 28 days apart
gptkbp:emergencyServices 2022 monkeypox outbreak
gptkbp:excludes replicating vaccinia virus
https://www.w3.org/2000/01/rdf-schema#label JYNNEOS
gptkbp:manufacturer Bavarian Nordic
gptkbp:routeOfAdministration subcutaneous injection
gptkbp:sideEffect fatigue
headache
muscle pain
injection site reactions
gptkbp:storage -20°C
gptkbp:type non-replicating live attenuated vaccine
gptkbp:WHOPrequalified yes
gptkbp:bfsParent gptkb:ACAM2000
gptkbp:bfsLayer 7